Please login to the form below

Not currently logged in
Email:
Password:

malignant glioma

This page shows the latest malignant glioma news and features for those working in and with pharma, biotech and healthcare.

BMS signs $1.74bn deal to boost immuno-oncology portfolio

BMS signs $1.74bn deal to boost immuno-oncology portfolio

malignant cells. . ... and malignant glioma.

Latest news

  • BMS' Opdivo set for early access in UK BMS' Opdivo set for early access in UK

    Until now, the only PIM granted under the scheme was for Northwest Biotherapeutics' cell-based therapy DCVax-L for a form of brain cancer known as malignant glioma.

  • FDA grants orphan status to Activartis’ brain cancer immunotherapy FDA grants orphan status to Activartis’ brain cancer immunotherapy

    Regulator says AV0113 has potential in rare cancer malignant glioma. Activartis received a boost this week when the US Food and Drug Administration (FDA) granted orphan drug status to its investigational ... The Austria-based biotech said the US

  • Roche's Avastin gains Japanese approval for brain cancer Roche's Avastin gains Japanese approval for brain cancer

    The Japanese drug regulator has approved Roche's Avastin (bevacizumab) for malignant glioma and newly diagnosed glioblastoma (GBM), in combination with radiotherapy and temozolomide chemotherapy. ... The estimated number of newly diagnosed malignant

  • Ark files documentation on Cerepro

    gene-based therapy for the treatment of operable malignant glioma (brain cancer). ... Malignant glioma is a fatal form of brain tumour that is usually confined to the brain.

  • Close but no cigar

    Both are being reviewed by the EMEA for the treatment of head and neck cancer and glioma, respectively. ... glioma, compared with patients receiving standard care alone (either surgery and radiotherapy or surgery and radiotherapy plus temozolomide).

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics